JZG could reduce the levels of ERS related GRP78, PERK, EIF2α and NFκB mRNA and protein, mediating its mechanism in improving liver injury in NAFLD rats induced by low-dose CCl4. Here, HSPA5 is linked to metabolic dysfunction-associated steatotic liver disease.